Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the champ study

HIGHLIGHTS

• who: Sofie Olsson Hau from the The CHAMP study is an ongoing prospective, singlearm observational study registered in clinicaltrialsgov as , [22]. All patients with a histologically or cytologically confirmed diagnosis of pancreatic or other periampullary adenocarcinoma undergoing adjuvant or palliative chemotherapy treatment in the Department of Oncology, Sku00e5ne University Hospital have been invited to participate, and the first patient was included in November, . Clinical and pathology data are compiled at study entry with radiological and clinical follow-up being performed at three-month intervals. Serial blood sampling during chemotherapy treatment is performed by a dedicated research nurse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.